Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial

INTRODUCTION: Long COVID-19, where symptoms persist 12 weeks after the initial SARS-CoV-2-infection, is a substantial problem for individuals and society in the surge of the pandemic. Common symptoms are fatigue, postexertional malaise and cognitive dysfunction. There is currently no effective treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjellberg, Anders, Abdel-Halim, Lina, Hassler, Adrian, El Gharbi, Sara, Al-Ezerjawi, Sarah, Boström, Emil, Sundberg, Carl Johan, Pernow, John, Medson, Koshiar, Kowalski, Jan H, Rodriguez-Wallberg, Kenny A, Zheng, Xiaowei, Catrina, Sergiu, Runold, Michael, Ståhlberg, Marcus, Bruchfeld, Judith, Nygren-Bonnier, Malin, Lindholm, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638753/
https://www.ncbi.nlm.nih.gov/pubmed/36323462
http://dx.doi.org/10.1136/bmjopen-2022-061870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638753/
https://www.ncbi.nlm.nih.gov/pubmed/36323462
http://dx.doi.org/10.1136/bmjopen-2022-061870

Ejemplares similares